Pharma sales buoy Novartis's second quarter, but earnings down 10%
16 July 2009
Sita Shah
Please Login to read the full article.
16 July 2009
Sita Shah
sita.shah@informa.com
Sustained growth in pharmaceutical sales drove Novartis's second quarter net sales, but a stronger dollar caused earnings to fall by 10% to $2 billion. Basic EPS fell by 9% to $0.90.
Novartis's pharmaceuticals division was the only one to post growth in dollar terms, Novartis's reporting...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
